Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06122649
What this trial is testing

Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

Who this might be right for
Plaque Psoriasis
Amgen 203
Large-scale testing (Phase 3)Study completedNCT03410992
What this trial is testing

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 435
Not applicableStudy completedNCT00705900
What this trial is testing

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
NeoStrata Company, Inc. 60
Large-scale testing (Phase 3)Ended earlyNCT00090129
What this trial is testing

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Arthritis, Psoriatic
EMD Serono 854
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150988
What this trial is testing

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT01225731
What this trial is testing

Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 355
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Large-scale testing (Phase 3)Study completedNCT01139580
What this trial is testing

The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis

Who this might be right for
Psoriasis
Stiefel, a GSK Company 363
Large-scale testing (Phase 3)Study completedNCT04167462
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Who this might be right for
Psoriasis
Bristol-Myers Squibb 220
Not applicableLooking for participantsNCT07234591
What this trial is testing

Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisModerate to Severe Plaque Psoriasis
Usynova Pharmaceuticals Ltd. 140
Post-approval studies (Phase 4)Study completedNCT02274792
What this trial is testing

Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 132
Testing effectiveness (Phase 2)Study completedNCT01748539
What this trial is testing

Clinical Study of KHK4827

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Co., Ltd. 140
Testing effectiveness (Phase 2)Ended earlyNCT05044234
What this trial is testing

Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 156
Large-scale testing (Phase 3)Study completedNCT03504852
What this trial is testing

Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 331
Early research (Phase 1)Study completedNCT04203433
What this trial is testing

DLX105-DMP in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
DelArrivo, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00320216
What this trial is testing

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 320
Large-scale testing (Phase 3)Study completedNCT00689481
What this trial is testing

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies

Who this might be right for
Psoriasis
Stiefel, a GSK Company 323
Large-scale testing (Phase 3)Looking for participantsNCT04772079
What this trial is testing

Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 153
Large-scale testing (Phase 3)Study completedNCT05073315
What this trial is testing

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 425
Testing effectiveness (Phase 2)Study completedNCT03421197
What this trial is testing

Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 426
Next Page